Design Therapeutics Inc. (DSGN)
NASDAQ: DSGN
· Real-Time Price · USD
5.35
0.19 (3.68%)
At close: Aug 15, 2025, 3:59 PM
5.33
-0.37%
After-hours: Aug 15, 2025, 04:04 PM EDT
Design Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 588K | 588K | 588K | 838K | 838K | 838K | 838K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 33K | 53K | 84K |
Cost of Revenue | 613K | 612K | 596K | 585K | 569K | 561K | 557K | 554K | 539K | 509K | 466K | 413K | 322K | 221K | 129K | 2.75M | 4.64M | 5.69M |
Gross Profit | -170K | -169K | -153K | -585K | -569K | -561K | -557K | -554K | -539K | -509K | -466K | -413K | -322K | -221K | -129K | -2.72M | -4.58M | -5.6M |
Operating Income | -74.93M | -68.4M | -62.38M | -60.81M | -63.39M | -70.94M | -78.19M | -82.46M | -82.83M | -75.87M | -67.59M | -59.33M | -51.47M | -43.52M | -35.83M | -28.57M | -19.61M | -13.39M |
Interest Income | 8.23M | 5.75M | 3.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -63.49M | -56.2M | -49.59M | -47.78M | -50.53M | -58.67M | -66.86M | -72.36M | -74.28M | -69.34M | -63.31M | -57.03M | -50.65M | -43.28M | -35.53M | -28.32M | -19.32M | -13.13M |
Net Income | -63.49M | -56.2M | -49.59M | -47.78M | -50.53M | -58.67M | -64.5M | -67.83M | -68.25M | -62.68M | -58.9M | -54.8M | -49.9M | -43.18M | -35.53M | -28.32M | -19.32M | -13.13M |
Selling & General & Admin | 19.78M | 18.48M | 18.03M | 17.61M | 18.8M | 19.8M | 21.13M | 22.16M | 21.48M | 20.29M | 18.98M | 17.63M | 15.54M | 13.86M | 11.05M | 8.45M | 6.14M | 3.91M |
Research & Development | 55.15M | 49.77M | 44.06M | 42.77M | 44.15M | 50.85M | 56.92M | 60.31M | 61.35M | 55.58M | 48.61M | 41.7M | 35.93M | 29.66M | 24.78M | 20.15M | 13.52M | 9.56M |
Other Expenses | -149K | -149K | -149K | n/a | -137K | -137K | -137K | -137K | n/a | n/a | 105K | 167K | 186K | 237K | 132K | 76K | 120K | 90K |
Operating Expenses | 74.78M | 68.1M | 61.94M | 60.38M | 62.82M | 70.52M | 77.92M | 82.32M | 82.83M | 75.87M | 67.59M | 59.33M | 51.47M | 43.52M | 35.83M | 28.57M | 19.61M | 13.39M |
Interest Expense | n/a | n/a | n/a | 129K | 129K | 129K | 129K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 76K | 76K | 76K | 76K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 74.93M | 68.4M | 62.38M | 60.81M | 63.39M | 70.94M | 78.19M | 82.46M | 82.83M | 75.87M | 67.59M | 59.33M | 51.47M | 43.52M | 35.83M | 28.57M | 19.61M | 13.39M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 10.91K | -2.35M | -4.52M | -6.01M | -6.66M | -4.41M | -2.29M | -807K | -167K | -62K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 56.86M | 56.76M | 56.68M | 56.62M | 56.56M | 56.49M | 56.15M | 55.99M | 55.95M | 55.91M | 55.86M | 55.78M | 55.67M | 55.51M | 55.36M | 55.16M | 55.08M | 17.63M |
Shares Outstanding (Diluted) | 56.86M | 56.76M | 56.68M | 56.62M | 56.56M | 56.49M | 56.15M | 55.99M | 55.95M | 55.91M | 55.86M | 55.78M | 55.67M | 55.51M | 55.36M | 55.16M | 55.08M | 17.63M |
EPS (Basic) | -1.12 | -0.99 | -0.88 | -0.85 | -0.9 | -1.05 | -1.15 | -1.21 | -1.22 | -1.12 | -1.06 | -0.99 | -0.91 | -0.79 | -0.86 | -0.8 | -0.68 | -0.59 |
EPS (Diluted) | -1.12 | -0.99 | -0.88 | -0.85 | -0.9 | -1.05 | -1.15 | -1.21 | -1.22 | -1.12 | -1.06 | -0.99 | -0.91 | -0.79 | -0.86 | -0.8 | -0.68 | -0.59 |
EBITDA | -74.47M | -67.79M | -61.79M | -60.23M | -62.82M | -70.39M | -77.65M | -81.94M | -82.34M | -75.42M | -67.19M | -58.96M | -51.19M | -43.31M | -35.7M | -28.51M | -19.59M | -11.89M |
EBIT | -72.44M | -68.4M | -62.38M | -60.81M | -63.39M | -70.94M | -78.19M | -82.46M | -82.83M | -75.87M | -67.59M | -59.33M | -51.47M | -43.52M | -35.83M | -28.57M | -19.61M | -13.37M |
Depreciation & Amortization | 613K | 612K | 596K | 585K | 569K | 561K | 557K | 554K | 539K | 509K | 466K | 413K | 322K | 221K | 129K | 51K | 21K | 1.47M |